The Carlyle Group has named Tomofumi Matsuyama (pictured), a former executive at Morgan Stanley, as a managing director of its Japan buyout team.
The firm described the move as part of an effort to expand its private equity business in the country. Matsuyama will focus on large corporate carve-out opportunities mainly in the technology and industrials...
Ascendent Capital Partners has joined Xuan Ruiguo, the chairman and founder of Hong Kong-listed industrial control systems maker China Automation Group, in a take-private offer that values the company at HK$1.5 billion ($197 million).
Australian investment firm Leap Capital has raised A$50 million ($34 million) for a venture debt fund that will target established, revenue-generating companies locally.
Hansoh Pharmaceutical Group, a Chinese drug developer that counts Hillhouse Capital and Boyu Capital among its investors, has raised HK$7.86 billion ($1 billion) through a Hong Kong IPO.
Fidelity International has announced plans to spin-out its proprietary investment arm Eight Roads within the year pending regulatory and shareholder approvals.